Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Zinc is effective for treating various skin conditions, including warts and acne.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Procyanidin compounds from grape seeds were found to significantly increase mouse hair growth.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.